EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genome-wide mapping of fluoroquinolone-stabilized DNA gyrase cleavage sites displays drug specific effects that correlate with bacterial persistence

Juechun Tang, Mark P Brynildsen iD

Nucleic Acids Research · 22.02.2023 · 51 (3) · 1208-1228

DOI: 10.1093/nar/gkac1223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 12.01.2023. Verfasst von Juechun Tang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biological Engineering, Princeton University, Princeton, NJ 08544, USA. Hauptthemen laut MEDLINE: Fluoroquinolones, DNA Gyrase. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial persisters are rare phenotypic variants that are suspected to be culprits of recurrent infections. Fluoroquinolones (FQs) are a class of antibiotics that facilitate bacterial killing by stabilizing bacterial type II topoisomerases when they are in a complex with cleaved DNA. In Escherichia coli, DNA gyrase is the primary FQ target, and previous work has demonstrated that persisters are not spared from FQ-induced DNA damage. Since DNA gyrase cleavage sites (GCSs) largely govern the sites of DNA damage from FQ treatment, we hypothesized that GCS characteristics (e.g. number, strength, location) may influence persistence. To test this hypothesis, we measured genome-wide GCS distributions after treatment with a panel of FQs in stationary-phase cultures. We found drug-specific effects on the GCS distribution and discovered a strong negative correlation between the genomic cleavage strength and FQ persister levels. Further experiments and analyses suggested that persistence was unlikely to be governed by cleavage to individual sites, but rather survival was a function of the genomic GCS distribution. Together, these findings demonstrate FQ-specific differences in GCS distribution that correlate with persister levels and suggest that FQs that better stabilize DNA gyrase in cleaved complexes with DNA will lead to lower levels of persistence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluoroquinolonesDNA GyraseAnti-Bacterial AgentsBacteriaDNA DamageDrug Resistance, BacterialDNA, Bacterial

Substanzen

FluoroquinolonesDNA GyraseAnti-Bacterial AgentsDNA, Bacterial

Autor:innen und Institutionen

  • Department of Chemical and Biological Engineering, Princeton University, Princeton, NJ 08544, USA.

ORCID-Profile: Mark P Brynildsen

Förderung

  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Tang, J., & Brynildsen, M. P. (2023). Genome-wide mapping of fluoroquinolone-stabilized DNA gyrase cleavage sites displays drug specific effects that correlate with bacterial persistence. Nucleic Acids Research, 51(3), 1208-1228. https://doi.org/10.1093/nar/gkac1223

Vancouver

Tang J, Brynildsen MP. Genome-wide mapping of fluoroquinolone-stabilized DNA gyrase cleavage sites displays drug specific effects that correlate with bacterial persistence. Nucleic Acids Research. 2023;51(3):1208-1228. doi:10.1093/nar/gkac1223

BibTeX
@article{Tang2023,
  author = {Tang, Juechun and Brynildsen, Mark P},
  title = {Genome-wide mapping of fluoroquinolone-stabilized DNA gyrase cleavage sites displays drug specific effects that correlate with bacterial persistence},
  journal = {Nucleic Acids Research},
  year = {2023},
  volume = {51},
  number = {3},
  pages = {1208--1228},
  doi = {10.1093/nar/gkac1223}
}
Kostenlos starten →